SMI-32 antibody against non-phosphorylated neurofilaments identifies a subpopulation of cultured cortical neurons hypersensitive to kainate toxicity
- 14 July 1995
- journal article
- Published by Elsevier in Neuroscience Letters
- Vol. 194 (1-2) , 1-4
- https://doi.org/10.1016/0304-3940(95)11698-v
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Cortical neurones exhibiting kainate-activated Co2+uptake are selectively vulnerable to AMPA/kainate receptor-mediated toxicityNeurobiology of Disease, 1994
- Cortical neurones with Ca2+permeable AMPA/kainate channels display distinct receptor immunoreactivity and are GABAergicNeurobiology of Disease, 1994
- Differences in Ca2+ permeability of AMPA-type glutamate receptor channels in neocortical neurons caused by differential GluR-B subunit expressionNeuron, 1994
- Subunit composition at the single-cell level explains functional properties of a glutamate-gated channelNeuron, 1994
- The cortical lesion of Huntington's disease: Further neurochemical characterization, and reproduction of some of the histological and neurochemical features by N‐methyl‐D‐aspartate lesions of rat cortexAnnals of Neurology, 1992
- Agonist-activated cobalt uptake identifies divalent cation—Permeable kainate receptors on neurons and glial cellsNeuron, 1991
- Quantitative analysis of a vulnerable subset of pyramidal neurons in Alzheimer's disease: I. Superior frontal and inferior temporal cortexJournal of Comparative Neurology, 1990
- Degeneration of pyramidal projection neurons in Huntington's disease cortexAnnals of Neurology, 1990
- Non-NMDA receptor-mediated neuronal injury in Alzheimer's disease?Neurobiology of Aging, 1989
- Monoclonal antibody to neurofilament protein (SMI‐32) labels a subpopulation of pyramidal neurons in the human and monkey neocortexJournal of Comparative Neurology, 1989